NEW YORK (GenomeWeb News) – The stocks of Clinical Data, Caliper Life Sciences, Sequenom, and Third Wave Technologies were added to the small cap Russell 2000 Index, which was reconstituted on June 27.
 
Separately, Illumina’s stock was moved to the Russell 1000, a large-cap index, from the Russell 2000. Joining Illumina in that Index is Hologic, the medical imaging and diagnostics firm that is in the process of acquiring Third Wave for nearly $600 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.